Elaborate, a New York-based provider of a tool that doctors and their staff use to deliver contextualized, action-oriented lab results to patients, raised $10M in Seed funding.
The round was led by Tusk Venture Partners, with participation from Founder Collective, Company Ventures, Bling Ventures, Arkitekt Ventures, Elliot Cohen, Sara Wajnberg, Scott Belsky, Sean and Peter Glass.
The company intends to use the funds to grow its team and deliver a more deeply embedded practitioner experience for select EMRs.
Led by CEO Nicole Bocskocksy, Elaborate provides a platform for practitioners to share lab results that tell patients what their health data means and what to do next. The company’s technology integrates with doctors’ EMRs and analyzes patient data with its proprietary clinical insights engine, enabling doctors to send a personalized report summarizing patients’ key findings.
The technology is responsible for covering 500,000 patients and has integrations live with 65+ EMRs.
FinSMEs
27/01/2023